Pfizer May Face Neurontin Marketing Class Action, Judge Says ...
April 17 (Bloomberg) — Pfizer Inc. may face a class-action lawsuit by health-insurance companies on claims its Warner- Lambert unit improperly marketed the epilepsy drug Neurontin for unapproved uses, a judge said. Read More… skydiving Dieting With Success white tail deer understanding bipolar